Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor organoid biobank-new platform for medical research
Xuexue Xie, Xinyu Li, Wei Song
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine
Sanae El Harane, Bochra Zidi, Nadia El Harane, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1001-1001
Open Access | Times Cited: 63
Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development
Dongxi Xiang, Aina He, Rong Zhou, et al.
Theranostics (2024) Vol. 14, Iss. 8, pp. 3300-3316
Open Access | Times Cited: 10
Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy
Jie Mei, Xingjian Liu, Huixiang Tian, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 6
Hepatobiliary organoid research: the progress and applications
Rui-Qi Zou, Yu-Shi Dai, Fei Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Advances and Applications of Cancer Organoids in Drug Screening and Personalized Medicine
Yujia Yang, Ya‐Jie Kong, Jinlei Cui, et al.
Stem Cell Reviews and Reports (2024) Vol. 20, Iss. 5, pp. 1213-1226
Closed Access | Times Cited: 5
Organoid-based personalized medicine: from tumor outcome prediction to autologous transplantation
Abel Soto-Gamez, Jeremy P. Gunawan, Lara Barazzuol, et al.
Stem Cells (2024) Vol. 42, Iss. 6, pp. 499-508
Open Access | Times Cited: 4
Patient-derived organoids in precision cancer medicine
Le Tong, Weiyingqi Cui, Boya Zhang, et al.
Med (2024)
Open Access | Times Cited: 4
Toxoflavin analog D43 exerts antiproliferative effects on breast cancer by inducing ROS-mediated apoptosis and DNA damage
Tingyue Wu, Wenjing Liu, Hui Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine
Jessica Kalla, Janette Pfneissl, Theresia Mair, et al.
Cellular Oncology (2024)
Open Access | Times Cited: 2
Liver and bile duct organoids and tumoroids
Xuanming Luo, Yuda Gong, Zijun Gong, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117104-117104
Open Access | Times Cited: 2
Mini-organs with big impact: Organoids in liver cancer studies
Muhammad Babar Khawar, YAJUN WANG, ANEEQA MAJEED, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 5, pp. 677-688
Open Access | Times Cited: 5
Advances in the study of gastric organoids as disease models
Yiyang Liu, De-Kun Wu, Jibing Chen, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 5, pp. 1725-1736
Open Access | Times Cited: 1
Living Biobanks of Organoids: Valuable Resource for Translational Research
Wenqing Huang, Zhaoting Xu, Shuang Li, et al.
Biopreservation and Biobanking (2024)
Closed Access | Times Cited: 1
Hepatocellular-Carcinoma-Derived Organoids: Innovation in Cancer Research
Carlo Airola, Maria Pallozzi, Eleonora Cesari, et al.
Cells (2024) Vol. 13, Iss. 20, pp. 1726-1726
Open Access | Times Cited: 1
Patient-Derived Organoids: A Game-Changer in Personalized Cancer Medicine
Mohammad Hadi Abbasian, Navid Sobhani, Mahsa Mollapour Sisakht, et al.
Stem Cell Reviews and Reports (2024)
Closed Access | Times Cited: 1
Organ mimicking technologies and their applications in drug discovery
Yueyang Qu, Jiaming Ye, Bingcheng Lin, et al.
Intelligent Pharmacy (2023) Vol. 1, Iss. 2, pp. 73-89
Open Access | Times Cited: 3
Current aspects in biobanking for personalised oncology investigations and treatments
Liliana Policiuc, Andreea Nuțu, Oana Zănoagă, et al.
Medicine and Pharmacy Reports (2023) Vol. 96, Iss. 3, pp. 235-245
Open Access | Times Cited: 2
KRAS-driven cancer models for in vivo pharmacology and drug discovery
Seema Chugh, Lukas E. Dow, Mallika Singh, et al.
Elsevier eBooks (2024), pp. 93-118
Closed Access
“Monitoring inflammatory, immune system mediators, and mitochondrial changes related to brain metabolism during space flight”
Darcy Tocci, Tomas Ducai, C A Barry Stoute, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Closing Editorial: Colorectal Cancer—A Molecular Genetics Perspective
Ehsan Gharib
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12604-12604
Open Access
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy
Sébastien Taurin, Reem Alzahrani, Sahar Aloraibi, et al.
Translational Oncology (2024) Vol. 51, pp. 102226-102226
Closed Access
Leveraging Data from Spontaneous Animal Disease Models to Streamline Pharmaceutical Research: A Tale of Two Species
Jonathan P. Mochel, Karin Allenspach
(2023)
Open Access | Times Cited: 1
Tumor Organoid as a Drug Screening Platform for Cancer Research
Reyhaneh Mahbubi Arani, Niloufar Yousefi, Amir Ali Hamidieh, et al.
Current Stem Cell Research & Therapy (2023) Vol. 19, Iss. 9, pp. 1210-1250
Closed Access | Times Cited: 1
The Need to Set up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte d’Azur, Nice, France)
Christophe Bontoux, Aubiège Marcovich, Samantha Goffinet, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 7, pp. 1076-1076
Open Access
Page 1

Scroll to top